Comparison between Methotrexate vs Leflunomide
| Parameter | Methotrexate | Leflunomide |
|---|---|---|
| Class | DMARD | DMARD |
| Mechanism | Folate antagonist | Pyrimidine synthesis inhibition |
| Onset | Gradual | Gradual |
| Monitoring | Regular labs | Regular labs |
| Dosing | Weekly | Daily |
| Half-life | Long | Very long |
| Reversal Agent | Leucovorin | Cholestyramine |
| Bleeding Risk | Moderate | Moderate |
| Indications | RA/autoimmune | RA/autoimmune |
| Renal Use | Caution | Caution |
| Pregnancy Use | Contraindicated | Contraindicated |
| Drug Interactions | High | High |
| Adherence Sensitivity | High | High |
| Best Use Case | First-line RA | Alternative DMARD |
| Cost | Low | Moderate |
| Monitoring Burden | High | High |
| Clinical Flexibility | Moderate | Moderate |
| Real-world Convenience | Moderate | Moderate |
| Overall Verdict | Standard | Alternative |
| Food Interactions | None | None |